Cargando…

Fragile X Syndrome: Recent Research Updates toward Capturing Treatments’ Improvement in Clinical Trials

Detalles Bibliográficos
Autores principales:	Budimirovic, Dejan B., Protic, Dragana D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599739/ https://www.ncbi.nlm.nih.gov/pubmed/36291209 http://dx.doi.org/10.3390/brainsci12101276

Ejemplares similares

Fragile X Syndrome: From Molecular Aspect to Clinical Treatment
por: Protic, Dragana D., et al.
Publicado: (2022)

Fragile X-Associated Disorders in Serbia: Baseline Quantitative and Qualitative Survey of Knowledge, Attitudes and Practices Among Medical Professionals
por: Budimirovic, Dejan B., et al.
Publicado: (2018)

Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders
por: Trajković, Jelena, et al.
Publicado: (2022)

Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
por: Budimirovic, Dejan B., et al.
Publicado: (2017)

Fragile X Syndrome: Lessons Learned from the Most Translated Neurodevelopmental Disorder in Clinical Trials
por: Duy, Phan Q., et al.
Publicado: (2017)

Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and Colombia: A Model for Other Developing Countries?
por: Protic, Dragana, et al.
Publicado: (2021)

Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
por: Lee, Anna W., et al.
Publicado: (2018)

New Targeted Treatments for Fragile X Syndrome
por: Protic, Dragana, et al.
Publicado: (2019)

Arbaclofen in fragile X syndrome: results of phase 3 trials
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2017)

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
por: Luu, Skylar, et al.
Publicado: (2020)

Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2022)

Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin‐two cases
por: Protic, Dragana, et al.
Publicado: (2019)

Genomic studies in fragile X premutation carriers
por: Lozano, Reymundo, et al.
Publicado: (2014)

Towards Mechanism-Based Treatments for Fragile X Syndrome
por: Kumari, Daman, et al.
Publicado: (2019)

Best Practices in Fragile X Syndrome Treatment Development
por: Erickson, Craig A., et al.
Publicado: (2018)

Fragile X-Associated Neuropsychiatric Disorders (FXAND)
por: Hagerman, Randi J., et al.
Publicado: (2018)

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment
por: Palumbo, Joseph M., et al.
Publicado: (2023)

Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study
por: Brašić, James Robert, et al.
Publicado: (2022)

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2022)

A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments
por: Budimirovic, Dejan B., et al.
Publicado: (2020)

Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study
por: Budimirovic, Dejan B., et al.
Publicado: (2021)

Fragile X Premutation
por: Tassone, Flora, et al.
Publicado: (2014)

Fragility Fractures in Orthopaedics: An Update
por: Hou, Zhiyong, et al.
Publicado: (2017)

Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome
por: Brašić, James R., et al.
Publicado: (2020)

Fragile X targeted pharmacotherapy: lessons learned and future directions
por: Erickson, Craig A., et al.
Publicado: (2017)

Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study
por: Brašić, James Robert, et al.
Publicado: (2021)

Narrative Review: Update on the Molecular Diagnosis of Fragile X Syndrome
por: Ciobanu, Cristian-Gabriel, et al.
Publicado: (2023)

Phenotypic variability to medication management: an update on fragile X syndrome
por: Elhawary, Nasser A., et al.
Publicado: (2023)

Minocycline and MMPs: towards treatment for Fragile X syndrome
Publicado: (2011)

Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017)

Editorial for the Fragile X Syndrome Genetics Special Issue: May 2023
por: Godler, David E., et al.
Publicado: (2023)

Closing the Gender Gap in Fragile X Syndrome: Review of Females with Fragile X Syndrome and Preliminary Research Findings
por: Bartholomay, Kristi L., et al.
Publicado: (2019)

Sjogren’s Syndrome: Recent Updates
por: Skarlis, Charalampos, et al.
Publicado: (2022)

The challenges of clinical trials in fragile X syndrome
por: Jacquemont, Sébastien, et al.
Publicado: (2013)

Research Gaps in Fragile X Syndrome: An Updated Literature Review to Inform Clinical and Public Health Practice
por: Raspa, Melissa, et al.
Publicado: (2023)

Fragile X Syndrome
por: McLennan, Yingratana, et al.
Publicado: (2011)

Fragile X Syndrome
por: Saldarriaga, Wilmar, et al.
Publicado: (2014)

Editorial: Recent advances in mechanisms and therapeutics for Fragile X Syndrome and autism
por: Molinaro, Gemma, et al.
Publicado: (2023)

Health systems research in fragile settings
por: Ager, Alastair, et al.
Publicado: (2019)

Translation in fragile X: no home runs in the first at-bat
por: Veenstra-VanderWeele, Jeremy
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ql5n8trd1qjufln7nhuftq87up